Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 4—April 2024
Research Letter

Crimean-Congo Hemorrhagic Fever Virus Seroprevalence in Human and Livestock Populations, Northern Tanzania

Ellen C. HughesComments to Author , William de Glanville, Tito Kibona, Blandina Theophil Mmbaga, Melinda K. Rostal, Emanuel S. Swai, Sarah Cleaveland, Felix Lankester, Brian J. Willett, and Kathryn J. Allan
Author affiliations: University of Liverpool Institute of Infection Veterinary and Ecological Sciences, Liverpool, UK (E.C. Hughes); University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, Scotland, UK (E.C. Hughes, W. de Glanville, S. Cleaveland, K.J. Allan); Washington State University, Pullman, Washington, USA (E.C. Hughes, F. Lankester); Nelson Mandela African Institute of Science and Technology, Arusha, Tanzania (T. Kibona); Global Animal Health Tanzania, Arusha, Tanzania (T. Kibona, F. Lankester); Kilimanjaro Christian Medical University College, Kilimanjaro, Tanzania (B.T. Mmbaga); EcoHealth Alliance, New York, New York, USA (M.K. Rostal); Ministry of Agriculture Livestock and Fisheries, Dodoma, Tanzania (E.S. Swai); MRC-University of Glasgow Centre for Virus Research, Glasgow, UK (B.J. Willet)

Main Article

Table

Seroprevalence of Crimean-Congo hemorrhagic fever virus in human and livestock populations, northern Tanzania*

Species
 No. tested
 Overall seroprevalence (95% CI)
 Seroprevalence range per village (95% CI)
 Moran I statistic (p value)
Low
 High
Cattle 3,015 49.6 (40.0–59.2) 5.3 (1.2–9.4) 76.6 (70.3–82.8) −0.09 (0.60)
Sheep 2,059 27.8 (17.0–40.6) 0.0 (0–3.9) 70.3 (55.5–85.0) −0.09 (0.57)
Goats 2,382 33.8 (21.7–47.5) 0.0 (0–5.8) 79.6 (68.3–90.8) −0.10 (0.61)
Human 351 15.1 (8.5–23.8) 0.0 (0.0–16.1) 50 (30.7–69.2) 0.43 (0.001)

*Serum samples were collected in northern in 2016 and tested for antibodies to Crimean-Congo hemorrhagic fever virus. Moran I statistic and associated p value are shown for the village level (Appendix).

Main Article

Page created: March 01, 2024
Page updated: March 21, 2024
Page reviewed: March 21, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external